AR051664A1 - Agente contra la demodicosis - Google Patents

Agente contra la demodicosis

Info

Publication number
AR051664A1
AR051664A1 ARP050104675A ARP050104675A AR051664A1 AR 051664 A1 AR051664 A1 AR 051664A1 AR P050104675 A ARP050104675 A AR P050104675A AR P050104675 A ARP050104675 A AR P050104675A AR 051664 A1 AR051664 A1 AR 051664A1
Authority
AR
Argentina
Prior art keywords
demodychosis
agent against
agent
demodicosis
dogs
Prior art date
Application number
ARP050104675A
Other languages
English (en)
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35614662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR051664(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of AR051664A1 publication Critical patent/AR051664A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente se refiere al uso de lactonas macrocíclicas para el tratamiento de demodicosis, especialmente en perros.
ARP050104675A 2004-11-09 2005-11-08 Agente contra la demodicosis AR051664A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004053964A DE102004053964A1 (de) 2004-11-09 2004-11-09 Mittel gegen Demodikose

Publications (1)

Publication Number Publication Date
AR051664A1 true AR051664A1 (es) 2007-01-31

Family

ID=35614662

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050104675A AR051664A1 (es) 2004-11-09 2005-11-08 Agente contra la demodicosis
ARP170101975A AR109263A2 (es) 2004-11-09 2017-07-14 Composición que comprende moxidectina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP170101975A AR109263A2 (es) 2004-11-09 2017-07-14 Composición que comprende moxidectina

Country Status (16)

Country Link
US (1) US9662309B2 (es)
EP (1) EP1811990B1 (es)
AR (2) AR051664A1 (es)
AU (1) AU2005304103B2 (es)
BR (2) BRPI0517966B1 (es)
DE (1) DE102004053964A1 (es)
DK (1) DK1811990T3 (es)
ES (1) ES2711329T3 (es)
HU (1) HUE041365T2 (es)
LT (1) LT1811990T (es)
PL (1) PL1811990T3 (es)
PT (1) PT1811990T (es)
SI (1) SI1811990T1 (es)
TR (1) TR201901390T4 (es)
TW (1) TWI432205B (es)
WO (1) WO2006050816A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2947453B1 (fr) * 2009-07-03 2011-08-19 Akil Sa Medicament antiparasitaire pour application topique contre les affections dues au demodex
CN103641873B (zh) * 2013-12-17 2015-10-28 华北制药集团爱诺有限公司 一种阿维菌素的制备方法
US20170232024A1 (en) * 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CN114681453A (zh) * 2014-12-22 2022-07-01 英特维特国际股份有限公司 异噁唑啉化合物用于治疗蠕形螨病的用途
RU2568869C1 (ru) * 2015-01-16 2015-11-20 Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") Способ лечения демодекоза собак
RU2634265C1 (ru) * 2016-10-18 2017-10-24 Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр Тюменский научный центр Сибирского отделения Российской академии наук (ТюмНЦ СО РАН) Способ лечения демодекоза собак
KR20200111177A (ko) 2017-12-15 2020-09-28 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
AU2019401653A1 (en) * 2018-12-21 2021-07-15 ELANCO US, Inc. Parasiticidal formulations and use thereof
AU2020208145B2 (en) * 2019-01-16 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
SI3815677T1 (sl) 2019-10-30 2023-12-29 Krka, D.D., Novo Mesto Stabilni veterinarski sestavek, ki obsega moksidektin in imidakloprid
WO2023111333A1 (en) * 2021-12-17 2023-06-22 Bayer Animal Health Gmbh Topical administration of composition comprising 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in cats

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (es) 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
DE3727648A1 (de) * 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
NZ233680A (en) * 1989-05-17 1995-02-24 Beecham Group Plc Avermectins and milbemycins and compositions thereof
ES2081880T3 (es) 1989-09-11 1996-03-16 American Cyanamid Co Derivados 13-alquil-23-imino- y 13-halo-23-imino de compuestos ll-f28249 y su uso como agentes endo- y ectoparasiticidas, insecticidas, acaricidas y nematocidas.
GB9024927D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel treatment
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
PE20011289A1 (es) * 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
DE10117676A1 (de) * 2001-04-09 2002-10-10 Bayer Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
LT1610613T (lt) * 2003-04-04 2017-03-27 Merial, Inc. Vietinio taikymo antihelmintinės veterinarinės kompozicijos
US7514464B2 (en) * 2003-12-18 2009-04-07 Pfizer Limited Substituted arylpyrazoles

Also Published As

Publication number Publication date
SI1811990T1 (sl) 2019-03-29
DE102004053964A1 (de) 2006-05-11
DK1811990T3 (en) 2019-03-11
BRPI0517966B1 (pt) 2023-09-26
AU2005304103A1 (en) 2006-05-18
EP1811990B1 (de) 2018-11-21
LT1811990T (lt) 2019-02-25
PL1811990T3 (pl) 2019-05-31
AR109263A2 (es) 2018-11-14
WO2006050816A1 (de) 2006-05-18
AU2005304103B2 (en) 2012-02-02
ES2711329T3 (es) 2019-05-03
TR201901390T4 (tr) 2019-02-21
BR122019002159B1 (pt) 2021-08-17
BRPI0517966A (pt) 2008-10-28
HUE041365T2 (hu) 2019-05-28
PT1811990T (pt) 2019-02-19
EP1811990A1 (de) 2007-08-01
US9662309B2 (en) 2017-05-30
TW200626162A (en) 2006-08-01
US20080039519A1 (en) 2008-02-14
TWI432205B (zh) 2014-04-01

Similar Documents

Publication Publication Date Title
AR051664A1 (es) Agente contra la demodicosis
CL2009000200A1 (es) Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune.
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
CL2007002649A1 (es) Composicion farmaceutica que comprende 2-[6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil]-4-fluoro-benzonitrilo; y uso para el tratamiento de la diabetes.
CL2012000707A1 (es) Compuestos derivados de [5-(pirrolo[1,2-c][1.2.3]triazin-7-il)tetrahidrofuran-2-il]metanol; composición farmacéutica; y su uso para el tratamiento de la hepatitis c.
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
BRPI0717219A2 (pt) "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica."
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
IT1392903B1 (it) Composizione comprendente un'associazione di principi attivi per uso nel trattamento topico della calvizie
MEP8509A (en) Combination treatment for diabetes mellitus
CL2007001710A1 (es) Compuestos derivados de amino-pirazolopiridina sustituidos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como tumores, artritis reumatoide, enfermedades de crecimiento vascular desregulado, entre otras.
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
CR11259A (es) Bromhidrato de bupropion y aplicaciones terapueticas
AR052322A1 (es) Compuestos de n-benzoil-estaurosporina, procesos para su preparacion y composicion farmaceutica
CL2008002082A1 (es) Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades.
UY29387A1 (es) Imidazoles sustituidos con heterociclilamida.
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
GT200600106A (es) Agentes endoparasiticidas
AR053775A1 (es) Nonadepsipeptidos acilados ii
AR066864A1 (es) Composicion parasiticida veterinaria, uso de la misma y metodo para el tratamiento o control de una infestacion o infeccion parasiticida en un animal homeotermico
BRPI0910884A2 (pt) composição imunogênica, método para tratar ou prevenir infecção ou doença estafilocócicas, e, uso de uma composição imunogênica.

Legal Events

Date Code Title Description
FB Suspension of granting procedure